Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Azacitadine and Entinostat in Patients With Metastatic Colorectal Cancer

NCT01105377 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01105377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01105377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Azacitadine and Entinostat in Patients With Metastatic Colorectal Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2010
Completion date
May 31, 2014
Enrollment
47 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent colon cancer, recurrent rectal cancer, stage iv colon cancer, stage iv rectal cancer